Biotech

All Articles

Cognition's stage 2 SHINE information blemish Alzheimer's possibility

.Knowledge Rehabs' stage 2 SHINE test has taken a number of the appeal off the Alzheimer's health co...

BMS axes bispecific months after filing to operate stage 3 test

.Bristol Myers Squibb has had a whiplash change of heart on its BCMA bispecific T-cell engager, halt...

Charles Baum takes control of Terremoto as CEO

.Charles Baum, M.D., Ph.D., who oversaw Mirati Rehabs' $ 5.8 billion purchase to Bristol Myers Squib...

Asarina to close after efforts to companion Tourette's medicine fall short

.After communicating to much more than 200 providers to partner a Tourette disorder treatment that r...

Novartis markers $150M upfront bispecifics take care of Dren Bio

.Novartis has had some misfortune with bispecific antitoxins in the past, however judging by the pha...

AstraZeneca plants an EGFR plant with Pinetree bargain worth $45M

.Pinetree Therapies will certainly assist AstraZeneca vegetation some trees in its own pipe along wi...

GRO collects $60M series B to take gout treatment into facility

.GRO Biosciences has ended the week along with an added $60.3 thousand in the bank, which the health...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava loses chief executive officer

.Invite to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...